Stonepine Capital Management as of June 30, 2025
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 58 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Adma Biologics (ADMA) | 13.4 | $14M | 750k | 18.21 | |
| Evolus (EOLS) | 8.3 | $8.4M | 917k | 9.21 | |
| Zevra Therapeutics Com New (ZVRA) | 6.7 | $6.8M | 776k | 8.81 | |
| Verastem Com New (VSTM) | 5.9 | $6.1M | 1.5M | 4.15 | |
| Indivior Ord | 5.1 | $5.2M | 350k | 14.74 | |
| ACADIA Pharmaceuticals (ACAD) | 4.8 | $4.9M | 225k | 21.57 | |
| Enanta Pharmaceuticals (ENTA) | 4.5 | $4.6M | 604k | 7.56 | |
| Tela Bio (TELA) | 4.0 | $4.0M | 2.1M | 1.94 | |
| Xoma Royalty Corporation Com New (XOMA) | 3.8 | $3.8M | 152k | 25.20 | |
| Iteos Therapeutics | 3.0 | $3.1M | 310k | 9.97 | |
| Day One Biopharmaceuticals I (DAWN) | 2.9 | $2.9M | 450k | 6.50 | |
| Surrozen Com New (SRZN) | 2.7 | $2.7M | 306k | 8.94 | |
| Biosante Pharmaceuticals (ANIP) | 2.5 | $2.5M | 39k | 65.25 | |
| Ardelyx (ARDX) | 2.1 | $2.2M | 555k | 3.92 | |
| Anika Therapeutics (ANIK) | 2.0 | $2.0M | 191k | 10.58 | |
| Aytu Biopharma (AYTU) | 1.7 | $1.8M | 813k | 2.18 | |
| Inhibikase Therapeutics Com New (IKT) | 1.4 | $1.4M | 734k | 1.95 | |
| Geron Corporation (GERN) | 1.4 | $1.4M | 1.0M | 1.41 | |
| Heron Therapeutics (HRTX) | 1.3 | $1.4M | 657k | 2.07 | |
| Nektar Therapeutics Com New (NKTR) | 1.3 | $1.3M | 50k | 25.84 | |
| Y Mabs Therapeutics | 1.3 | $1.3M | 285k | 4.51 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.2 | $1.2M | 42k | 29.57 | |
| Vanda Pharmaceuticals (VNDA) | 1.2 | $1.2M | 250k | 4.72 | |
| Kalvista Pharmaceuticals (KALV) | 1.1 | $1.1M | 100k | 11.30 | |
| Alumis (ALMS) | 1.0 | $1.0M | 350k | 3.00 | |
| Myomo Com New (MYO) | 1.0 | $988k | 457k | 2.16 | |
| Rezolute Com New (RZLT) | 1.0 | $977k | 219k | 4.46 | |
| Xeris Pharmaceuticals (XERS) | 0.9 | $958k | 205k | 4.67 | |
| Pmv Pharmaceuticals (PMVP) | 0.9 | $897k | 846k | 1.06 | |
| Syndax Pharmaceuticals (SNDX) | 0.9 | $870k | 93k | 9.37 | |
| Acasti Pharma (GRCE) | 0.9 | $869k | 293k | 2.97 | |
| Kezar Life Sciences Com New (KZR) | 0.8 | $778k | 170k | 4.58 | |
| AngioDynamics (ANGO) | 0.8 | $765k | 77k | 9.92 | |
| Achieve Life Sciences (ACHV) | 0.7 | $753k | 333k | 2.26 | |
| Aclaris Therapeutics (ACRS) | 0.7 | $698k | 491k | 1.42 | |
| Vir Biotechnology (VIR) | 0.6 | $655k | 130k | 5.04 | |
| Bioage Labs (BIOA) | 0.6 | $624k | 151k | 4.13 | |
| Liquidia Corporation Com New (LQDA) | 0.6 | $623k | 50k | 12.46 | |
| An2 Therapeutics (ANTX) | 0.6 | $577k | 545k | 1.06 | |
| Kiora Pharmaceuticals (KPRX) | 0.5 | $513k | 178k | 2.88 | |
| Spero Therapeutics (SPRO) | 0.4 | $455k | 157k | 2.90 | |
| Hillevax | 0.4 | $450k | 226k | 1.99 | |
| Theratechnologies Com New | 0.4 | $446k | 189k | 2.36 | |
| Pulmonx Corp (LUNG) | 0.4 | $378k | 146k | 2.59 | |
| Health Catalyst (HCAT) | 0.4 | $377k | 100k | 3.77 | |
| Establishment Labs Holdings Ord (ESTA) | 0.3 | $299k | 7.0k | 42.71 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.3 | $298k | 30k | 9.92 | |
| Abeona Therapeutics Com New (ABEO) | 0.3 | $256k | 45k | 5.68 | |
| Savara (SVRA) | 0.2 | $194k | 85k | 2.28 | |
| In8bio Com New (INAB) | 0.2 | $172k | 82k | 2.09 | |
| Nuvation Bio Com Cl A (NUVB) | 0.2 | $166k | 85k | 1.95 | |
| Kura Oncology (KURA) | 0.1 | $144k | 25k | 5.77 | |
| Eliem Therapeutics (CLYM) | 0.1 | $144k | 116k | 1.24 | |
| Calcimedica Com New (CALC) | 0.1 | $136k | 85k | 1.60 | |
| Monte Rosa Therapeutics (GLUE) | 0.1 | $135k | 30k | 4.51 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.1 | $127k | 109k | 1.16 | |
| Boundless Bio (BOLD) | 0.1 | $107k | 106k | 1.01 | |
| Coherus Biosciences (CHRS) | 0.0 | $46k | 63k | 0.73 |
